Turmeric and green tea: a recipe for B-Chronic Lymphocytic Leukemia

Por Angelo, Laura S., Kurzrock, Razelle
Publicado em 2009

NF2/Merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations

Por Schroeder, Rebecca Dunbar, Angelo, Laura S., Kurzrock, Razelle
Publicado em 2013

A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R): Implications for Inhibition of the IGF-1R signal

Por Janku, Filip, Huang, Helen J., Angelo, Laura S., Kurzrock, Razelle
Publicado em 2013

Molecular Imaging of Bcr-Abl Phosphokinase in a Xenograft Model

Por Wu, Ji Yuan, Yang, David J., Angelo, Laura S., Kohanim, Saady, Kurzrock, Razelle
Publicado em 2009

R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis

Por Huang, Helen J., Angelo, Laura S., Rodon, Jordi, Sun, Michael, Kuenkele, Klaus-Peter, Parsons, Henrique A., Trent, Jonathan C., Kurzrock, Razelle
Publicado em 2011

Practical NK cell phenotyping and variability in healthy adults

Por Angelo, Laura S., Banerjee, Pinaki P., Monaco-Shawver, Linda, Rosen, Joshua B., Makedonas, George, Forbes, Lisa R., Mace, Emily M., Orange, Jordan S.
Publicado no Immunol Res (2015)

Germline PTPRD Mutations in Ewing Sarcoma: Biologic and Clinical Implications

Por Jiang, Yunyun, Janku, Filip, Subbiah, Vivek, Angelo, Laura S., Naing, Aung, Anderson, Peter M., Herzog, Cynthia E., Fu, Siqing, Benjamin, Robert S., Kurzrock, Razelle
Publicado em 2013

Severe cutaneous human papilloma virus infection associated with Natural Killer cell deficiency following stem cell transplantation for severe combined immunodeficiency

Por Kamili, Qurat-ul-Ain, Seeborg, Filiz O, Saxena, Kapil, Nicholas, Sarah K, Banerjee, Pinaki P, Angelo, Laura S, Mace, Emily M, Forbes, Lisa R, Martinez, Caridad, Wright, Teresa S, Orange, Jordan S., Hanson, Imelda Celine
Publicado no J Allergy Clin Immunol (2014)

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab

Por Falchook, Gerald S, Wheler, Jennifer J, Naing, Aung, Jackson, Edward F, Janku, Filip, Hong, David, Ng, Chaan S, Tannir, Nizar M, Lawhorn, Kristie N, Huang, Mei, Angelo, Laura S, Vishwamitra, Deeksha, Hess, Kenneth, Howard, Adrienne N, Parkhurst, Kristin L, Amin, Hesham M, Kurzrock, Razelle
Publicado no Oncotarget (2014)

Biallelic mutations in IRF8 impair human NK cell maturation and function

Por Mace, Emily M., Bigley, Venetia, Gunesch, Justin T., Chinn, Ivan K., Angelo, Laura S., Care, Matthew A., Maisuria, Sheetal, Keller, Michael D., Togi, Sumihito, Watkin, Levi B., LaRosa, David F., Jhangiani, Shalini N., Muzny, Donna M., Stray-Pedersen, Asbjørg, Coban Akdemir, Zeynep, Smith, Jansen B., Hernández-Sanabria, Mayra, Le, Duy T., Hogg, Graham D., Cao, Tram N., Freud, Aharon G., Szymanski, Eva P., Savic, Sinisa, Collin, Matthew, Cant, Andrew J., Gibbs, Richard A., Holland, Steven M., Caligiuri, Michael A., Ozato, Keiko, Paust, Silke, Doody, Gina M., Lupski, James R., Orange, Jordan S.
Publicado no J Clin Invest (2016)